Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/15/23
End: 09/30/25
Due: 09/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin | NCT06521190 | Acousia Therapeutics GmbH | user2@example.com | None | 2023-12-15 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |